Magnetic Stimulation for Parkinson Disease
Trial
Phase 1
Completed
Aug. 17, 2006
Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients
Trial
N/A
Completed
Aug. 14, 2006
Valerian to Improve Sleep in Patients With Parkinson's Disease
Trial
Phase 2
Completed
July 25, 2006
Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System
Trial
Phase 2
Completed
July 12, 2006
Sensory Cues for Freezing in Parkinson's Disease
Trial
N/A
Unknown
June 22, 2006
Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease
Trial
Phase 3
Completed
June 6, 2006
Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.
Trial
Phase 3
Completed
June 6, 2006
Catechol Thioethers in Parkinson's Disease
Trial
N/A
Completed
March 22, 2006
Cohorts and Collections: Clinical and Genetic Study of Parkinson's Disease and Epilepsies
Trial
N/A
Terminated
Feb. 28, 2006
Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease
Trial
Phase 3
Unknown
Feb. 2, 2006
Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease
Trial
N/A
Unknown
Dec. 29, 2005
Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months
Trial
Phase 2
Completed
Dec. 15, 2005
Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease
Trial
Phase 3
Completed
Dec. 15, 2005
Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)
Trial
Phase 3
Terminated
Dec. 14, 2005
Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug
Trial
Phase 2
Completed
Dec. 6, 2005
Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients
Trial
N/A
Completed
Nov. 30, 2005
Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy
Trial
Phase 1
Completed
Oct. 19, 2005
Ambulatory Assessment of Motor State in Patients With Parkinson's Disease in Real Daily Life
Trial
N/A
Unknown
Sept. 15, 2005
A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.
Trial
Phase 3
Completed
Sept. 4, 2005
Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease
Trial
Phase 3
Completed
Sept. 1, 2005